Ambac Financial Group (OSG) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
14 Jan, 2026Executive summary
Achieved a milestone quarter with the acquisition of Beat Capital Partners, expanding the MGA platform from 5 to 19 and advancing the transition to a pure-play P&C business.
Specialty P&C premium production surged 86% year-over-year to $260 million in Q3 2024, with YTD premium reaching $611 million, driven by acquisitions and organic growth.
Announced and commenced a $50 million share buyback program, with up to $15 million allowed before the legacy business sale closes.
Received strong shareholder and PRA approval for the sale of the legacy financial guarantee business (AAC) for $420 million, with only one regulatory approval remaining and closing expected by early 2025.
Total revenues rose to $114 million in Q3 2024 from $74 million in Q3 2023, reflecting growth in specialty P&C and insurance distribution.
Financial highlights
Reported a net loss of $28 million ($0.63 per diluted share) for Q3 2024, compared to net income of $66 million in Q3 2023, mainly due to $20 million in transaction and acquisition-related interest expenses.
Adjusted net loss was $19 million ($0.46 per diluted share), versus adjusted net income of $94 million in Q3 2023.
Gross written premium was $113.6 million, up 43% year-over-year; net premiums earned were $33.1 million, up 81%.
EBITDA for Q3 2024 was $6.3 million, down from $90.8 million in Q3 2023; Cirrata YTD EBITDA was $10 million with an 18% margin.
Stockholders' equity was $1.47 billion ($30.89/share) at September 30, 2024, up from $1.36 billion at December 31, 2023.
Outlook and guidance
Targeting over $1.4 billion in premium for 2025 and $70–$80 million EBITDA by 2028, with organic growth as the primary driver.
Anticipates becoming a pure-play P&C franchise after the sale of the legacy business, with rebranding expected in 2025.
Tracking well to previous guidance for gross written premiums and program fees, with some Q4 seasonality expected.
Proceeds from the AAC sale will be used to repay Beat acquisition debt and support capital allocation.
Latest events from Ambac Financial Group
- Q4 2025 delivered strong premium and revenue growth, but net loss rose on acquisition costs.OSG
Q4 202524 Feb 2026 - AAC sale and Beat acquisition accelerate specialty P&C transformation and capital redeployment.OSG
Q2 20242 Feb 2026 - Legacy business sold to Oaktree and 60% of Beat acquired, accelerating specialty P&C focus.OSG
Investor Update31 Jan 2026 - Revenue up 27% and P&C premium up 70%, but net loss widened on higher expenses.OSG
Q1 20257 Jan 2026 - Record premium growth and margin gains offset by $548M net loss from legacy business sale.OSG
Q4 202423 Dec 2025 - Vote on $420M sale of AAC to Oaktree, executive pay, and adjournment; board recommends approval.OSG
Proxy Filing2 Dec 2025 - Shareholders to vote on $420M sale, board-backed, with new capital and governance terms.OSG
Proxy Filing2 Dec 2025 - Transformational year with strategic transactions, strong specialty insurance growth, and enhanced governance.OSG
Proxy Filing2 Dec 2025 - Vote requested on sale of Ambac Assurance Corporation and related executive compensation.OSG
Proxy Filing2 Dec 2025